Back to search
FDAFDA · Food and drugs·Recall number D-0117-2024

Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL Single-Dose Vial, 25 count carton, Ready to Use For Intravenous Infusion Only Preservative Free, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial NDC 51754-2131-1; Carton NDC 51754-2131-4).

Published November 29, 2023 · Recall initiated: October 18, 2023

Summary

FDA records drug Class I recall D-0117-2024, published November 29, 2023 and initiated October 18, 2023. Recalling firm: Exela Pharma Sciences LLC; Status: Ongoing; Reported quantity: 23,425 vials; Lot: Lot # 10001088 exp 07/31/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Silicone

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Exela Pharma Sciences LLC
Distributor
Nationwide
Lot
Lot # 10001088 exp 07/31/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL Single-Dose Vial, 25 count carton, Ready to Use For Intravenous Infusion Only Preservative Free, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial NDC 51754-2131-1; Carton NDC 51754-2131-4). recalled?

Yes. FDA published recall D-0117-2024 on November 29, 2023. Reported hazard: Presence of Particulate Matter: Silicone

What should I do if I have this product?

Voluntary: Firm initiated · Letter